Recherche
-
Absence of JAK2V617F Mutated Endothelial Colony-Forming Cells in Patients With JAK2V617F Myeloproliferative Neoplasms and Splanchnic Vein Thrombosis
(HemaSphere. vol. 4, n° 3, pp. e364, 2020-06)Article de revueLibre accès -
Description of a knock-in mouse model of JAK2V617F MPN emerging from a minority of mutated hematopoietic stem cells
(Blood. vol. 134, n° 26, pp. 2383–2387, 2019-12)Article de revueAccès réservé -
Platelets and neutrophils cooperate to induce increased neutrophil extracellular trap formation in JAK2V617F myeloproliferative neoplasms.
(Journal of Thrombosis and Haemostasis, 2023-09-09)Article de revue -
Platelet function studies in myeloproliferative neoplasms patients with Calreticulin or JAK2V617F mutation
(Research and Practice in Thrombosis and Haemostasis. vol. Vol. 7, n° Issue 2, pp. 100060, 2023-02)Article de revueLibre accès -
Role of red cell mass evaluation in myeloproliferative neoplasms with splanchnic vein thrombosis and normal hemoglobin value: a study of the France Intergroupe des Syndromes myeloprolifératifs.
(Haematologica, 2024-02-08)Article de revueLibre accès -
Assessment of circulating blood lymphocytes in adult patients on rituximab to treat immune thrombocytopenia: Circulating number of NK cells is associated with the response at 6 months.
(British Journal of Haematology, 2023-04-20)Article de revueLibre accès